Founded in 1994, CRISTALENS was initially a distributor of medical devices for cataract surgery. In 2006, the company created its own production unit of hydrophilic and hydrophobic intraocular lenses. In 2008, it has developed a new hydrophobic raw material (phenoxy ethyl acrylate) that allows less than 2.0 mm micro incisions. In 2013, Cristalens received the price of Industrial Innovation with this invention. In 2020 Cristalens Industrie was chosen by the European Commission in its "Horizon 2020" project for its latest innovation: Artis Symbiose®. This implant, thanks to its “Binocular Phase Continuity” technology, is designed to restore clear binocular vision to cataract patients for continuous sight from 40 to 90 cm, without any compromises on distance vision.